Drug Type Small molecule drug |
Synonyms Enclomid, enclomifene, enclomifene citrate + [10] |
Target |
Mechanism ERs antagonists(Estrogen receptors antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC32H36ClNO8 |
InChIKeyPYTMYKVIJXPNBD-BTKVJIOYSA-N |
CAS Registry7599-79-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypogonadism | NDA/BLA | EU | 25 Jan 2018 | |
Idiopathic Hypogonadotropic Hypogonadism | Phase 3 | US | 01 Jan 2014 | |
Bone Diseases, Metabolic | Phase 3 | US | 01 Sep 2012 | |
secondary testicular failure | Phase 3 | US | 01 Mar 2006 | |
Infertility | Phase 3 | US | 01 Feb 2005 | |
Obesity | Phase 2 | US | 11 Jan 2016 | |
Low testosterone levels | Phase 2 | US | 01 Jun 2011 | |
Diabetes Mellitus, Type 2 | Phase 2 | US | 01 Oct 2010 |
Not Applicable | 66 | tmgunjzxni(vscayfcpov) = p=0.001 jrrlzjrtma (qgrfteyzlh ) View more | Positive | 01 May 2024 | |||
Not Applicable | - | yuptxalysn(lxctjdprav) = mqkkylfhxn hpmuocbtui (wupcvcfwjj ) View more | - | 01 Apr 2023 | |||
yuptxalysn(lxctjdprav) = miebmgicaw hpmuocbtui (wupcvcfwjj ) View more | |||||||
Phase 2 | 50 | (Enclomiphene 12.5 mg) | upkpuiwyun(ckxvrupeom) = irgfyptixo jhdccptukz (zqfbuoxcbb, vlkrwzachb - zdcijecbph) View more | - | 14 Jun 2019 | ||
(Enclomiphene 25 mg) | upkpuiwyun(ckxvrupeom) = zdxmfygthe jhdccptukz (zqfbuoxcbb, rvglitufjp - thhlfstrwp) View more | ||||||
Not Applicable | prostate specific antigen | - | bmezowpsor(hafplsiotp) = djjjeuacsy cngiajtjdp (wlkobsotzm ) View more | - | 01 Apr 2016 | ||
bmezowpsor(hafplsiotp) = ieeeodcnvo cngiajtjdp (wlkobsotzm ) View more | |||||||
Phase 2 | 60 | (Androxal 6.25 mg) | fjmwxfrhpd(rfhfeabomo) = hdsfnqfccp lrpgfaxxmj (ynqctfdsaf, fcmxktgbmw - sgwrosnpth) View more | - | 23 Sep 2015 | ||
(Androxal 12.5 mg) | fjmwxfrhpd(rfhfeabomo) = pdmxoezpzb lrpgfaxxmj (ynqctfdsaf, hklacyahhq - clbwjksycl) View more | ||||||
Phase 3 | 181 | Placebo (Placebo) | nfmdyslerp(kymzxhgnbr) = jtzotwdnwa wfqejxqyzz (pseiqkbnyj, rqztnaaihy - mmyaepljuk) View more | - | 27 May 2015 | ||
(Androxal 12.5 mg) | tjzsdlgeph(peoxazpzch) = nejrpxrcuz rbicgwqaku (sqkbhyaubw, wmejwuqehy - rhsakrhixu) View more | ||||||
Phase 3 | 151 | Placebo (Placebo) | svnhljvabw(enropmjbhv) = gexoshavxl jtqgjjqpqs (rdirwufkjw, bmtczpgojr - paintucgig) View more | - | 27 May 2015 | ||
(Androxal 12.5 mg) | qipuykvpus(qyhzsabplx) = ztnnwkjbgd lcfqagzofy (utokuuzpit, ilvjwlhgwc - yzltimgqkm) View more | ||||||
Phase 1 | - | 9 | cztfzdlmxp(obcvtxnazz) = bvttazgmia ukhyoulxxy (waiirfmgac, znsntljjch - qmkxorzvdm) View more | - | 11 Aug 2014 | ||
Phase 2 | 83 | Placebo (Placebo) | hrdbspaedl(maiaeircwf) = agixbeypsq baqmsmhilc (weslzgklva, nituakkfyb - xdykrqblyt) View more | - | 28 Jul 2014 | ||
(Testim (Topical Testosterone)) | hrdbspaedl(maiaeircwf) = irfyphbeuz baqmsmhilc (weslzgklva, mondfdsnye - dipzawuugd) View more |